Parsec Financial Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$5.78M Sell
77,806
-66,154
-46% -$5.55M 0.24% 83
2022
Q4
$13.4M Sell
143,960
-15,046
-9% -$1.45M 0.6% 49
2022
Q3
$15.2M Sell
159,006
-118,953
-43% -$11.8M 0.76% 37
2022
Q2
$25.8M Sell
277,959
-63,206
-19% -$6.17M 1.25% 20
2022
Q1
$34.5M Sell
341,165
-18,207
-5% -$1.91M 1.47% 15
2021
Q4
$37.1M Sell
359,372
-4,621
-1% -$427K 1.54% 13
2021
Q3
$33.8M Sell
363,993
-21,601
-6% -$1.81M 1.44% 16
2021
Q2
$32.2M Buy
385,594
+7,220
+2% +$591K 1.51% 17
2021
Q1
$28.5M Buy
378,374
+9,157
+2% +$667K 1.46% 21
2020
Q4
$25.2M Sell
369,217
-1,296
-0.3% -$84.3K 1.36% 23
2020
Q3
$21.6M Buy
370,513
+8,886
+2% +$553K 1.32% 23
2020
Q2
$23.5M Buy
361,627
+11,516
+3% +$725K 1.5% 20
2020
Q1
$20.8M Buy
350,111
+6,718
+2% +$448K 1.56% 20
2019
Q4
$25.5M Sell
343,393
-1,947
-0.6% -$137K 1.49% 20
2019
Q3
$21.8M Buy
345,340
+719
+0.2% +$42.6K 1.36% 25
2019
Q2
$18.8M Buy
344,621
+42,942
+14% +$2.31M 1.17% 31
2019
Q1
$16.3M Buy
301,679
+17,640
+6% +$1.09M 1.03% 37
2018
Q4
$18.6M Buy
284,039
+7,666
+3% +$572K 1.35% 18
2018
Q3
$21.8M Buy
276,373
+4,799
+2% +$343K 1.37% 20
2018
Q2
$17.5M Sell
271,574
-3,034
-1% -$200K 1.18% 26
2018
Q1
$17.1M Buy
274,608
+2,705
+1% +$194K 1.17% 26
2017
Q4
$19.7M Sell
271,903
-11,489
-4% -$835K 1.34% 15
2017
Q3
$23M Buy
283,392
+2,155
+0.8% +$170K 1.67% 11
2017
Q2
$22.6M Buy
281,237
+7,097
+3% +$560K 1.79% 9
2017
Q1
$21.5M Buy
274,140
+3,759
+1% +$300K 1.79% 12
2016
Q4
$21.3M Sell
270,381
-4,197
-2% -$340K 1.86% 9
2016
Q3
$24.4M Buy
274,578
+1,519
+0.6% +$143K 2.21% 6
2016
Q2
$26.1M Sell
273,059
-873
-0.3% -$87K 2.51% 2
2016
Q1
$28.4M Sell
273,932
-4,236
-2% -$412K 2.82% 2
2015
Q4
$27.2M Sell
278,168
-3,721
-1% -$364K 2.82% 3
2015
Q3
$27.2M Buy
281,889
+206
+0.1% +$21.7K 2.96% 2
2015
Q2
$29.5M Sell
281,683
-135
-0% -$13.8K 2.97% 2
2015
Q1
$29.1M Sell
281,818
-1,750
-0.6% -$177K 2.93% 2
2014
Q4
$27.3M Buy
283,568
+196
+0.1% +$17.3K 2.86% 2
2014
Q3
$22.6M Buy
283,372
+12,352
+5% +$974K 2.47% 5
2014
Q2
$20.4M Buy
271,020
+722
+0.3% +$54.6K 2.23% 5
2014
Q1
$20.2M Buy
270,298
+13,014
+5% +$919K 2.29% 4
2013
Q4
$18.4M Buy
257,284
+8,867
+4% +$570K 2.16% 10
2013
Q3
$14.1M Buy
248,417
+3,091
+1% +$184K 1.83% 19
2013
Q2
$14M Buy
+245,326
New +$14.2M 1.9% 14

Other funds holding CVS

Parsec Financial Management's CVS Position: Q1 2023 in Review

Parsec Financial Management reduced its CVS Health (CVS) stake by 46% in Q1 2023, selling an estimated $5.55M and leaving 77,806 shares worth $5.78M. The position accounts for 0.24% of the portfolio, ranked #83.

Parsec Financial Management first reported a position in CVS in Q2 2013 and has held it in 40 quarters since. The position peaked at $37.1M in Q4 2021. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • Parsec Financial Management held 77,806 shares of CVS Health worth $5.78M as of Q1 2023.
  • Parsec Financial Management sold 66,154 CVS Health shares in Q1 2023, an estimated $5.55M.
  • CVS Health made up 0.24% of Parsec Financial Management's portfolio in Q1 2023, its #83 holding.
  • Parsec Financial Management first reported a position in CVS Health in Q2 2013 and has held it in 40 quarters since.
  • Parsec Financial Management's CVS Health position peaked at $37.1M in Q4 2021.
  • 2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Parsec Financial Management's 13F filing for Q1 2023, filed 6 Apr 2023.